EUVIMEDOpdag EUVIMED
Open access

Risk Factors for Adverse Outcome in Fetuses With Heterotaxy Syndrome and Congenital Heart Disease

Anita Szwast, Jill J Savla, Chris Penney, Priya Sharma, Jack Rychik

Prenatal Diagnosis · 2026

DOI: 10.1002/pd.70173 ↗

At a glance

Journal article in Prenatal Diagnosis, 2026. Written by Anita Szwast and 4 co-authors. Institution: Fetal Heart Program, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Heterotaxy Syndrome, Heart Defects, Congenital. Cited 1 times so far (Crossref); 35 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Fetuses with heterotaxy syndrome and congenital heart disease have high morbidity and mortality. We sought to identify risk factors impacting survival in the current era.

Method

Retrospective, single center cohort study of fetuses diagnosed with heterotaxy syndrome and congenital heart disease between January 2005 and December 2023. Prenatal echocardiographic parameters and clinical outcomes were recorded. Findings were compared between the right and left atrial isomerism subtypes. Univariate and multivariable logistic regression were utilized to identify prenatal variables predictive of fetal demise. Postnatal survival was examined with Kaplan‐Meier curves and univariate Cox proportional hazard models.

Results

The cohort consisted of 197 subjects: 97 with right atrial isomerism and 100 with left atrial isomerism. Median 5‐ and 10‐year survival was 71% (95% CI 64–80) and 68% (95% CI 60–77). Fetuses with left atrial isomerism had higher survival ( p = 0.028). In multivariable analysis, complete heart block (CHB) ( p < 0.001) and ventricular dysfunction ( p = 0.043) predicted fetal demise, whereas pulmonary venous obstruction ( p = 0.002) and CHB ( p < 0.001) predicted postnatal mortality. Major extra‐cardiac congenital anomaly did not influence postnatal survival ( p = 0.7).

Conclusion

CHB and pulmonary venous obstruction remain significant predictors of postnatal mortality in fetuses with concurrent heterotaxy syndrome and congenital heart disease.

Subjects

MeSH terms (MEDLINE)

Heterotaxy SyndromeHeart Defects, CongenitalHumansFemalePregnancyRetrospective StudiesRisk FactorsAdultUltrasonography, PrenatalEchocardiography

Authors and institutions

  • Fetal Heart Program, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Cite

APA

Szwast, A., Savla, J. J., Penney, C., Sharma, P., & Rychik, J. (2026). Risk Factors for Adverse Outcome in Fetuses With Heterotaxy Syndrome and Congenital Heart Disease. Prenatal Diagnosis. https://doi.org/10.1002/pd.70173

Vancouver

Szwast A, Savla JJ, Penney C, Sharma P, Rychik J. Risk Factors for Adverse Outcome in Fetuses With Heterotaxy Syndrome and Congenital Heart Disease. Prenatal Diagnosis. 2026. doi:10.1002/pd.70173

BibTeX
@article{Szwast2026,
  author = {Szwast, Anita and Savla, Jill J and Penney, Chris and Sharma, Priya and Rychik, Jack},
  title = {Risk Factors for Adverse Outcome in Fetuses With Heterotaxy Syndrome and Congenital Heart Disease},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70173}
}
Start for free →